.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,716,640

« Back to Dashboard

Claims for Patent: 5,716,640

Title: Method of producing sustained-release microcapsules
Abstract:A method of producing sustained-release microcapsules containing a biologically active substance from an W/O emulsion comprising an inner aqueous phase containing said biologically active substance and an external oil phase containing a biodegradable polymer, characterized in that microcapsules formed on microencapsulation of said biologically active substance with said biodegradable polymer are heated at a temperature not lower than the glass transition temperature of said biodegradable polymer but not so high as to cause aggregation of the microcapsules. This method enables the production of very useful sustained release microcapsules adapted to release a bologically active substance at a calculated rate over a protracted time period starting immediately following administration without an initial burst within one day following administration.
Inventor(s): Kamei; Shigeru (Takarazuka, JP), Yamada; Minoru (Kawanishi, JP), Ogawa; Yasuaki (Ohyamazaki-cho, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:08/705,348
Patent Claims: 1. A method of producing sustained-release microcapsules containing a biologically active substance from an W/O emulsion comprising an inner aqueous phase containing said biologically active substance and an external oil phase containing a biodegradable polymer, characterized in that microcapsules formed on microencapsulation of said biologically active substance with said biodegradable polymer are heated at a temperature not lower than the glass transition temperature of said biodegradable polymer but not so high as to cause aggregation of the microcapsules.

2. The method according to claim 1 wherein the biologically active substance is a peptide having a molecular weight of about 200 to 80,000.

3. The method according to claim 1 wherein the biologically active substance is luteinizing hormone releasing hormone or its derivatives.

4. The method according to claim 1 wherein the biodegradable polymer is an aliphatic polyester.

5. The method according to claim 4 wherein the aliphatic polyester is a homopolymer or copolymer of .alpha.-hydroxy acids, or a mixture of the homopolymer and/or copolymer.

6. The method according to claim 4 wherein the weight average molecular weight of the aliphatic ester is about 3,000 to 30,000.

7. The method according to claim 4 wherein the dispersity of the aliphatic ester is about 1.2 to 4.0.

8. The method according to claim 1 wherein the microcapsules are heated at a temperature of about 5.degree. to 40.degree. C. higher than the glass transition temperature of the biodegradable polymer.

9. The method according to claim 1 wherein the mean particle diameter ranges from about 1 to 300 .mu.m.

10. The method according to claim 1 wherein a heating is carried out after an antiaggregation agent is added to the microcapsules formed on microcapsulation.

11. Sustained-release microcapsules containing a biologically active substance which is produced by heating microcapsules formed on microencapsulation of said biologically active substance with a biodegradable polymer at a temperature not lower than the glass transition temperature of said biodegradable polymer but not so high as to cause aggregation of the microcapsules.

12. The sustained-release microcapsules containing a biologically active substance according to claim 11 wherein an antiaggregation agent is added to the microcapsules formed on microencapsulation.

13. An injectable preparation comprising sustained-release microcapsules containing a biologically active substance according to claim 11.

14. A method of producing sustained-release microcapsules containing a biologically active substance from an W/O emulsion comprising an inner aqueous phase containing said biologically active substance and an external oil phase containing a biodegradable polymer, wherein microcapsules formed on microencapsulation of said biologically active substance with said biodegradable polymer are heated at a temperature between that which not lower than the glass transition temperature of said biodegradable polymer and a temperature 40.degree. C. higher than said the glass transition temperature.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc